Pharmacotherapy With Pamidronate Disodium of Osteolytic Bone Metastases of Breast Cancer, Osteolytic Lesions of Multiple Myeloma, and Paget's Disease

Clinical Medicine. Therapeutics
doi 10.4137/cmt.s2166
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Implications for Osteolytic Bone Metastases

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases

Cancers
Cancer ResearchOncology
2020English

Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast Cancer

Cancer Research
Cancer ResearchOncology
2007English

Gene Therapy for Osteolytic Breast Cancer Bone Metastasis

2007English

Gene Therapy for Osteolytic Breast Cancer Bone Metastasis

2009English

Monitoring Tumor Metastases and Osteolytic Lesions With Bioluminescence and Micro CT Imaging

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2011English

Metalloproteinases and Osteoblast EGFR Signaling in Osteolytic Bone Metastasis of Breast Cancer

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

A Patient With Paget's Disease of Bone Treated With Etidronate Disodium.

Kurume Medical Journal
Medicine
1998English

Osteolytic Disease in IL-6 and Myc Dependent Mouse Model of Human Myeloma

Haematologica
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy